FDA DEVICE FACTS
Disposable Nitrile Examination Glove(Tested for use with Chemotherapy Drug)
Inner Mongolia Cureguard Medical Technology Co., Ltd.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
A patient examination glove is a disposable device intended for medical purposes that is worn on the examiner’s h ands to prevent contamination between patient and examiner. These gloves were tested for use with chemotherapy drugs, per ASTM D6978 -05 Standard Practice for Assessment of Resistance of Medical Gloves to Permeation by Chemotherapy Drugs. Chemotherapy Drug Concentration Breakthrough Detection Time in Minutes Carmustine (BCNU) 3.3 mg/ml (3,300 ppm) 22.0 Cisplatin 1.0 mg/ml(1,000 ppm) > 240 Cyclophosphamide (Cytoxan) 20.0 mg/ml(20,000 ppm) > 240 Dacarbazine (DTIC) 10.0 mg/ml(10,000 ppm) > 240 Doxorubicin HCl 2.0 mg/ml(2,000 ppm) > 240 Etoposide 20.0 mg/ml(20,000 ppm) > 240 Fluorouracil 50.0 mg/ml(50,000 ppm) > 240 Methotrexate 25 mg/ml(25,000 ppm) > 240 Mitomycin C 0.5 mg/ml(500 ppm) > 240 Paclitaxel 6.0 mg/ml(6,000 ppm) > 240 Thio Tepa 10.0 mg/ml(10,000 ppm) 59.2 Vincristine Sulfate 1.0 mg/ml(1,000 ppm) > 240
Please note that the following drugs have low permeation times: Carmustine (BCNU) 3.3 mg/ml 22.0 Minutes; Thio Tepa 10.0 mg/ml 59.2 Minutes.
Caution: Testing showed an average breakthrough time of 59.2 minutes with Thio- Tepa WARNING: Do not use with Carmustine.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。